These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 23072640

  • 1. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
    Gundara JS, Zhao JT, Gill AJ, Clifton-Bligh R, Robinson BG, Delbridge L, Sidhu SB.
    ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD, Chen SL, Schneider PD, Martinez SR.
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [Abstract] [Full Text] [Related]

  • 5. [Surgical management of medullary thyroid carcinoma. Personal experience].
    Geraci G, Pisello F, Tornambè A, Platia L, Sciumè C, Li Volsi F, Cupido F, Modica G.
    G Chir; 2007 Oct; 28(10):385-9. PubMed ID: 17915054
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
    Abraham D, Jackson N, Gundara JS, Zhao J, Gill AJ, Delbridge L, Robinson BG, Sidhu SB.
    Clin Cancer Res; 2011 Jul 15; 17(14):4772-81. PubMed ID: 21622722
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective lateral compartment neck dissection for thyroid cancer.
    Welch K, McHenry CR.
    J Surg Res; 2013 Sep 15; 184(1):193-9. PubMed ID: 23816244
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
    Esfandiari NH, Hughes DT, Yin H, Banerjee M, Haymart MR.
    J Clin Endocrinol Metab; 2014 Feb 15; 99(2):448-54. PubMed ID: 24276457
    [Abstract] [Full Text] [Related]

  • 15. The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
    Pennelli G, Galuppini F, Barollo S, Cavedon E, Bertazza L, Fassan M, Guzzardo V, Pelizzo MR, Rugge M, Mian C.
    Hum Pathol; 2015 Jan 15; 46(1):50-7. PubMed ID: 25316501
    [Abstract] [Full Text] [Related]

  • 16. A miRNA signature associated with human metastatic medullary thyroid carcinoma.
    Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF.
    Endocr Relat Cancer; 2013 Dec 15; 20(6):809-23. PubMed ID: 24127332
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
    Machens A, Holzhausen HJ, Lautenschläger C, Thanh PN, Dralle H.
    Cancer; 2003 Aug 15; 98(4):712-9. PubMed ID: 12910514
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.